REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/29/2026
Back to search
Official data from USPTO
EPIARX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/29/2026
Trademark type
Word
Nice classes
44
Filing date
06/10/2020
Registration date
06/29/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2021
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/05/2018
First use in commerce
01/15/2020
Drawing code
4
Owner type
16
Owner location
Washington, DC, US
Examiner
HETZEL, DANNEAN
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EPIARX LLC
Representatives
KEISHA HYLTON-RODIC HYLTON-RODIC LAW PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical care; Medical consultations; Medical consultations provided via phoneonline chat or videoconferencing; Medical consulting services in the field of disease infection control; Medical counseling; Medical diagnosis of skin diseases and conditions; medical diagnosis of cancer including skin cancerbreast cancerchronic degenerative diseasesobesitycause of death (autopsy)preventative care; Medical evaluation of tissue-based and body fluid-based specimensbiopsiesblood and urine; Medical screening; Medical services; Medical services for the treatment of skin cancer; Medical testing for diagnostic or treatment purposes; Consulting services in the field of medical care; Consulting services in the fields of diagnostic medical testing and nutrition; Genetic testing for medical purposes; Performing non-invasive cosmetic medical procedures; Providing medical aesthetic procedurestreating the skin with dermal fillers and botulinum toxin; Providing medical informationconsultancy and advisory services; Providing a web site featuring medical information
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/29/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/13/2021
PUBO
PUBLISHED FOR OPPOSITION
04/13/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2020
GNRT
NON-FINAL ACTION E-MAILED
09/16/2020
CNRT
NON-FINAL ACTION WRITTEN
09/16/2020
DOCK
ASSIGNED TO EXAMINER
09/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2020
NWAP
NEW APPLICATION ENTERED
06/13/2020
Continuous trademark protection
Get notified about every new filing that threatens EPIARX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.